{
  "meta": {
    "title": "Glycolysis",
    "url": "https://brainandscalpel.vercel.app/glycolysis-196a0a22.html",
    "scrapedAt": "2025-11-29T18:23:14.185Z"
  },
  "questions": [
    {
      "id": 6103,
      "choices": [
        {
          "id": 24381,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactate</span></p>"
        },
        {
          "id": 24382,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxaloacetate</span></p>"
        },
        {
          "id": 24383,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl-CoA</span></p>"
        },
        {
          "id": 24384,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A young woman with laboratory picture of normocytic anaemia and jaundice with splenomegaly was diagnosed to have RBC pyruvate kinase deficiency after a PBS showed spiculated cells. Due to the abnormal function of pyruvate kinase, less pyruvate is formed and the intermediates above pyruvate in the glycolytic pathway get accumulated. Which of the following products is not formed in appropriate amounts in the RBC due to the deficiency of pyruvate?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture3_vhplgH7.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p>",
      "unique_key": "Q9904988",
      "question_audio": null,
      "question_video": null,
      "map_id": 29829,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lactate&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyruvate kinase catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate in the final step of glycolysis, generating ATP. In pyruvate kinase deficiency, this reaction is impaired, resulting in reduced pyruvate production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In red blood cells, which rely exclusively on anaerobic glycolysis for energy production, pyruvate is normally converted to lactate by lactate dehydrogenase (LDH). This reaction regenerates NAD+ from NADH, allowing glycolysis to continue. When pyruvate kinase is deficient, less pyruvate is produced, consequently leading to decreased lactate formation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture4_OJApgRI.jpg\" alt=\"\" width=\"500\" height=\"166\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Oxaloacetate</strong>: Mature RBCs lack mitochondria and therefore do not contain the enzymes needed to convert pyruvate to oxaloacetate (via pyruvate carboxylase). Oxaloacetate is not normally produced in RBCs regardless of pyruvate kinase function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acetyl-CoA</strong>: Similar to oxaloacetate, acetyl-CoA formation from pyruvate requires the pyruvate dehydrogenase complex, which is located in mitochondria. Since mature RBCs lack mitochondria, they do not produce acetyl-CoA from pyruvate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glucose</strong>: RBCs do not synthesize glucose from pyruvate (gluconeogenesis). This process requires several enzymes that are not present in RBCs and also occurs primarily in the liver and kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This question tests understanding of RBC metabolism, particularly the consequences of pyruvate kinase deficiency. Pyruvate kinase deficiency is an inherited disorder that affects glycolysis in RBCs, leading to premature destruction of red blood cells (hemolytic anemia). The spiculated RBCs seen on peripheral blood smear are characteristic of this condition. The defect causes ATP depletion, accumulation of glycolytic intermediates upstream of the enzyme defect, and reduced production of downstream metabolites like lactate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 170; Vasudevan 9/e: 111.</span></p>",
      "correct_choice_id": 24381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6070,
      "choices": [
        {
          "id": 24250,
          "text": "<p><span style=\"font-size:12pt;\">Enolase</span></p>"
        },
        {
          "id": 24251,
          "text": "<p><span style=\"font-size:12pt;\">Phosphofructokinase</span></p>"
        },
        {
          "id": 24252,
          "text": "<p><span style=\"font-size:12pt;\">Pyruvate Kinase</span></p>"
        },
        {
          "id": 24253,
          "text": "<p><span style=\"font-size:12pt;\">Hexokinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A medical student is reviewing the glycolytic pathway and is attempting to identify the points of regulation within the process. She notes that certain steps are irreversible and thus play a key role in the regulation of glycolysis. Which of the following enzymes catalyzes a reaction in glycolysis that is not considered irreversible and therefore not a major regulatory point?</span></p>",
      "unique_key": "Q1805491",
      "question_audio": null,
      "question_video": null,
      "map_id": 29828,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Enolase</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Enolase catalyzes the second-to-last step in aerobic glycolysis, converting 2-phosphoglycerate into phosphoenolpyruvate. This step is reversible and not a major control point in the pathway. In contrast, the other enzymes listed catalyze irreversible steps and are tightly regulated to control the flow through the glycolytic pathway.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Phosphofructokinase</strong>: Catalyzes an irreversible step by converting fructose-6-phosphate to fructose-1,6-bisphosphate and is a major regulatory point of glycolysis.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pyruvate Kinase</strong>: Irreversibly Catalyzes the conversion of phosphoenolpyruvate to pyruvate, another regulatory step in glycolysis.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hexokinase</strong>: Irreversibly phosphorylates glucose to glucose-6-phosphate at the start of the glycolytic pathway and is allosterically inhibited by its product, making it a key regulatory enzyme.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Irreversible Steps of Glycolysis:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Hexokinase</span></li><li><span style=\"font-size:12.0pt;\">Phosphofructokinase</span></li><li><span style=\"font-size:12.0pt;\">Pyruvate Kinase</span></li></ul><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p170-172.</span></p>",
      "correct_choice_id": 24250,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6055,
      "choices": [
        {
          "id": 24190,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Aldolase and Pyruvate kinase</span></span></span></span></p>"
        },
        {
          "id": 24191,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Phosphofructokinase</span></span></span></span></p>"
        },
        {
          "id": 24192,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Hexokinase&nbsp;&nbsp; </span></span></span></span></p>"
        },
        {
          "id": 24193,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Phosphoglucose isomerase&nbsp;&nbsp; </span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 58-year-old male with type 2 diabetes starts a new oral hypoglycemic regimen. Soon after, he presents with anxiety, diaphoresis, and hunger, which quickly resolves upon consuming glucose. This clinical scenario underscores the importance of the initial enzymatic step in glycolysis following glucose ingestion. In the context of glycolytic pathway activation for immediate energy production, which enzyme is responsible for catalyzing the first reaction that glucose undergoes in this metabolic pathway?</span></span></span></span></span></p>",
      "unique_key": "Q2572587",
      "question_audio": null,
      "question_video": null,
      "map_id": 29821,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hexokinase&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong>Glycolysis </strong>is a process which <strong>converts glucose into pyruvate </strong>with production of <strong>ATP.&nbsp; </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The <strong>first step</strong> is when <strong>glucose</strong> is <strong>converted </strong>by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">hexokinase (option C)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> to <strong>glucose-6-phosphate.&nbsp; </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">When this compound interacts with enzyme </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Phosphoglucose isomerase (option D)</span></span></strong><span style=\"font-size:12.0pt\">, it<span style=\"color:black\"> forms<strong> fructose-6-phosphate </strong></span>which gets<span style=\"color:black\"> converted by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">phosphofructokinase</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> (</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">) to <strong>fructose 1,6-bisphosphate</strong>, which is then converted to <strong>glyceraldehyde </strong></span></span><span style=\"font-size:12.0pt\"><strong>3-phosphate</strong><span style=\"color:black\"><strong> </strong>by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">aldolase</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> (</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">A</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">After a <strong>number of enzymatic reactions,</strong> <strong>phosphoenol pyruvate</strong> is formed, which is converted to <strong>pyruvate-by-pyruvate</strong> <strong>kinase </strong>(option a) at the end.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aldolase and Pyruvate kinase</span></strong><span style=\"font-size:12.0pt\">: These enzymes function in the <strong>intermediate to later stages of glycolysis</strong> and are <strong>not</strong> involved in the<strong> initial phosphorylation of glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Phosphofructokinase</span></strong><span style=\"font-size:12.0pt\">: This enzyme plays a<strong> key</strong> regulatory role in<strong> glycolysis</strong> by converting<strong> fructose-6-phosphate to fructose-1,6-bisphosphate</strong>, but it is<strong> not</strong> the first enzyme in the pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Phosphoglucose isomerase</span></strong><span style=\"font-size:12.0pt\">: This <strong>enzyme acts</strong> second in the<strong> glycolytic pathway</strong>, converting <strong>glucose-6-phosphate</strong> <strong>to</strong> <strong>fructose-6-phosphate</strong>, following the action of<strong> hexokinase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\"><strong>Hexokinase catalyzes</strong> the<strong> first</strong> critical step in the<strong> glycolytic pathway</strong> by<strong> phosphorylating glucose</strong> to form <strong>glucose-6-phosphate</strong>. This reaction is essential for <strong>trapping glucose </strong>within the cell, <strong>enabling</strong> its subsequent metabolism in the <strong>glycolytic pathway </strong>to produce <strong>energy,</strong> particularly important in the context of<strong> restoring normal blood glucose levels</strong> after <strong>hypoglycemic</strong> episodes in <strong>diabetic</strong> <strong>patients.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">: Harper 30/e: p 168-172</span></span></strong></span></span></p>",
      "correct_choice_id": 24192,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6034,
      "choices": [
        {
          "id": 24106,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate dehydrogenase</span></p>"
        },
        {
          "id": 24107,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucokinase</span></p>"
        },
        {
          "id": 24108,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexokinase</span></p>"
        },
        {
          "id": 24109,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphofructokinase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a lecture on metabolic pathways, medical students were asked to identify the first committed step in glycolysis and the enzyme that catalyzes it. This step is crucial because it irreversibly commits the substrate to the glycolytic pathway. Which enzyme is responsible for this committed step in glycolysis?</span></p>",
      "unique_key": "Q5584516",
      "question_audio": null,
      "question_video": null,
      "map_id": 29826,
      "difficulty_level": "difficult",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) Phosphofructokinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>first committed step</strong> in glycolysis is catalyzed by <strong>phosphofructokinase-1 (PFK-1)</strong>, which converts:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fructose-6-phosphate → Fructose-1,6-bisphosphate</strong></span></p><p><span style=\"font-size:12.0pt;\">This step is considered \"committed\" because, after this conversion, the sugar molecule is no longer available for alternative pathways (such as glycogenesis or the pentose phosphate pathway). It must proceed through glycolysis.</span></p><p><span style=\"font-size:12.0pt;\">Additionally, this step is <strong>irreversible</strong> under cellular conditions and is <strong>highly regulated</strong> — it represents the <strong>rate-limiting step</strong> of glycolysis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A — Pyruvate dehydrogenase:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">This enzyme catalyzes the decarboxylation of pyruvate to acetyl-CoA, which is part of the <strong>linking step</strong> between glycolysis and the citric acid cycle, not glycolysis itself.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B — Glucokinase:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">Glucokinase catalyzes <strong>glucose → glucose-6-phosphate</strong> in the <strong>liver and pancreas</strong>, and the product can still be shunted into other pathways like glycogenesis or the pentose phosphate pathway.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C — Hexokinase:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">Hexokinase also converts <strong>glucose to glucose-6-phosphate</strong> in most tissues, but this is not the committed step because glucose-6-phosphate is a central intermediate that can enter multiple pathways beyond glycolysis.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The <strong>first committed step</strong> of glycolysis is catalyzed by <strong>phosphofructokinase-1 (PFK-1)</strong>. It ensures that glucose carbons are committed to energy production via glycolysis. This step is irreversible, highly regulated, and marks a metabolic \"point of no return\" for the glucose molecule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PFK-1 is a key <strong>allosteric enzyme</strong> — activated by AMP and fructose-2,6-bisphosphate and inhibited by ATP and citrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref:&nbsp;Harper 30/e p173</span></p>",
      "correct_choice_id": 24109,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6075,
      "choices": [
        {
          "id": 24269,
          "text": "<p>1</p>"
        },
        {
          "id": 24270,
          "text": "<p>2</p>"
        },
        {
          "id": 24271,
          "text": "<p>0</p>"
        },
        {
          "id": 24272,
          "text": "<p>4</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A medical student is studying the unique metabolic pathways of erythrocytes (red blood cells). Due to the absence of mitochondria, erythrocytes rely on glycolysis for ATP production. Within this context, the student is interested in the yield of ATP from glucose through the Rapoport-Luebering cycle. What is the net gain of ATP by this cycle in red blood cells from one molecule of glucose?</span></p>",
      "unique_key": "Q6857388",
      "question_audio": null,
      "question_video": null,
      "map_id": 29830,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. 0</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Red blood cells (erythrocytes) are unique in that they lack mitochondria, so they rely entirely on anaerobic glycolysis for ATP production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the normal Embden-Meyerhof glycolytic pathway:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">From 1 molecule of glucose, red blood cells normally produce:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">2 ATP (net gain).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, erythrocytes have a special side pathway called the Rapoport-Luebering shunt (or cycle), which diverts 1,3-bisphosphoglycerate (1,3-BPG) into 2,3-bisphosphoglycerate (2,3-BPG) instead of continuing down the standard glycolytic path.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is crucial for regulating hemoglobin’s oxygen affinity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this shunt:</span></p><ol><li><span style=\"font-size:12.0pt;\">1,3-BPG is converted to 2,3-BPG by bisphosphoglycerate mutase.</span></li><li><span style=\"font-size:12.0pt;\">2,3-BPG is then hydrolyzed to 3-phosphoglycerate by 2,3-BPG phosphatase.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key point:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">In the normal glycolytic pathway, the conversion of 1,3-BPG to 3-phosphoglycerate yields 1 ATP (via substrate-level phosphorylation).</span></li><li><span style=\"font-size:12.0pt;\">In the Rapoport-Luebering cycle, this ATP production step is bypassed, meaning no ATP is generated in this part of the cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, when glucose is metabolized exclusively via the Rapoport-Luebering cycle, the net ATP gain is 0.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">Understand RBC Metabolism:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Learn the Rapoport-Luebering Cycle:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p173, 174</span></p>",
      "correct_choice_id": 24271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6354,
      "choices": [
        {
          "id": 25385,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5&rsquo;AMP </span></span></span></p>"
        },
        {
          "id": 25386,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose 2, 6 Bisphosphate</span></span></span></p>"
        },
        {
          "id": 25387,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose 6 Phosphate</span></span></span></p>"
        },
        {
          "id": 25388,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citrate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a competitive quiz on cellular metabolism among medical students, a challenging question is posed regarding the regulation of Phosphofructokinase-1 (PFK-1), a key enzyme in the glycolytic pathway. The quizmaster asks which of the following molecules does not serve as an activator for PFK-1, contrary to the common regulatory mechanisms of this crucial enzyme. The options given are:</span></span></span></p>",
      "unique_key": "Q2904756",
      "question_audio": null,
      "question_video": null,
      "map_id": 29827,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Citrate. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Citrate </strong>is actually an <strong>inhibitor of Phosphofructokinase-1 (PFK-1),</strong> <strong>not an activator.</strong> It serves as a <strong>signal of abundant energy </strong>supply, thus<strong> inhibiting PFK-1</strong> to slow down <strong>glycolysis</strong> when the<strong> cell&#39;s energy</strong> needs are<strong> low</strong> or when<strong> biosynthetic precursors are abundan</strong>t. <strong>Citrate accumulation</strong> in the <strong>cytosol,</strong> indicative of a<strong> high rate </strong>of <strong>oxidative metabolism </strong>and <strong>sufficient energy levels</strong>, leads to the <strong>inhibition of PFK-1,</strong> thereby <strong>reducing glycolytic flux.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>other options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 5&rsquo;AMP:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Acts as an <strong>activator of PFK-1,</strong> signaling<strong> low energy </strong>status in the cell and thus <strong>promoting glycolysis</strong> to generate <strong>ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fructose 2,6-Bisphosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> One of the most <strong>potent activators</strong> of <strong>PFK-1</strong>, it enhances <strong>glycolysis</strong> even in the <strong>presence of ATP,</strong> thus allowing <strong>glycolysis</strong> to continue under various conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fructose 6-Phosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>not </strong>as direct an <strong>activator as fructose 2,6-bisphosphate</strong>, it is the <strong>substrate</strong> for<strong> PFK-1 </strong>and thus necessary for <strong>its activity; </strong>however, its role as <strong>an activator</strong> is<strong> not</strong> as significant as the <strong>other molecules</strong> listed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citrate is an Inhibitor of Phosphofructokinase-I.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture10.jpg\" style=\"height:336px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Harper 30/e p188.</span></strong></span></span></p>",
      "correct_choice_id": 25388,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6417,
      "choices": [
        {
          "id": 25637,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose</span></span></span></p>"
        },
        {
          "id": 25638,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amino Acids</span></span></span></p>"
        },
        {
          "id": 25639,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketone body</span></span></span></p>"
        },
        {
          "id": 25640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a fasting state, which substrate is primarily used by Red Blood Cells (RBCs) for energy? </span></span></p>",
      "unique_key": "Q9054273",
      "question_audio": null,
      "question_video": null,
      "map_id": 29825,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Glucose </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>RBCs</strong> are always <strong>dependent </strong>on use of <strong>glucose for energy</strong> irrespective of fed or fasting state of the body due to<strong> lack of mitochondria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Amino Acids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RBCs do not</strong> utilize<strong> amino acids</strong> for <strong>energy production. Amino acids</strong> are primarily<strong> used by muscles</strong> and other <strong>tissues for protein synthesis </strong>or as an <strong>energy source</strong> through<strong> gluconeogenesis in the liver.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ketone Body:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ketone bodies are <strong>used as</strong> an<strong> alternative energy source</strong> by<strong> </strong>many tissues, including the <strong>brain,</strong> during <strong>prolonged fasting or starvation</strong>. However,<strong> RBCs do not </strong>use <strong>ketone bodies </strong>for energy due to their <strong>lack of mitochondria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fatty Acid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RBCs</strong> are also <strong>unable to oxidize fatty acids </strong>for energy. <strong>Fatty acid oxidation</strong> occurs in the <strong>mitochondria,</strong> which <strong>RBCs lack.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1_BuSFrTM.jpg\" style=\"height:514px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Harper 30/e p150.</span></strong></span></span></p>",
      "correct_choice_id": 25637,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7690,
      "choices": [
        {
          "id": 30728,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency</span></span></span></p>"
        },
        {
          "id": 30729,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase deficiency</span></span></span></p>"
        },
        {
          "id": 30730,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
        },
        {
          "id": 30731,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-Thalassemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23 days old infant with severe neonatal jaundice receives an exchange blood transfusion. Advised monthly red blood cell transfusion and splenectomy at 6 months of age. Histologic examination of the spleen reveals marked hemosiderosis and laboratory studies shows:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture15.jpg\" style=\"height:449px; width:700px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Analysis of red cell glycolytic intermediates shows markedly elevated concentrations of 2, 3-bisphosphoglycerate, 3-phosphoglycerate, 2-phosphoglycerate and PEP. Which is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q2106409",
      "question_audio": null,
      "question_video": null,
      "map_id": 29824,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase (PK) deficiency&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KEY POINTS:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Severe neonatal jaundice + elevated indirect bilirubin + exchange blood transfusion </strong>are suggestive of <strong>hemolysis.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low hemoglobin and hematocrit values + reticulocytosis</strong> &ndash; indicates <strong>anemia.</strong> </span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thus, <strong>hemolytic anemia</strong> is confirmed. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">levels of <strong>2,3-BPG, 3-PG, 2-PG, </strong>and <strong>PEP</strong> (all are <strong>distal glycolysis intermediates</strong>) are seen in <strong>blocks in glycolysis below phosphoenolpyruvate.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic anemia</strong> is associated with<strong> deficiencies </strong>of most of the <strong>enzymes of glycolysis, </strong>among which <strong>PK deficiency is the most common. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only<strong> hemolytic anemia</strong> induced by a <strong>PK deficiency</strong> <strong>meets all these criteria</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is the<strong> most </strong>common cause of<strong> hemolytic anemia. </strong>Patients may have <strong>hemolytic crises</strong> when <strong>stressed by</strong> certain <strong>oxidizing drugs, infections and by fava beans</strong>. Here glycolytic intermediates don&#39;t accumulate.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia HbS:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is the <strong>most </strong>common<strong> hemoglobinopathy </strong>with <strong>molecular defect in substitution of glutamate </strong>by <strong>valine at 6th position</strong> of the <strong>beta-chain</strong> &rarr; <strong>sickling of RBCs</strong> &rarr; <strong>block small vessels</strong> &rarr; clinical manifestations. But glycolytic intermediates do not accumulate here. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-Thalassemia: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Results from <strong>reduced synthesis of the hemoglobin B-chain </strong>&rarr; leads to an<strong> excess of x-globin chains</strong> &rarr; <strong>precipitate RBCs</strong> and prevent <strong>nascent red cells </strong>from<strong> maturing</strong>. <strong>Symptoms of anemia</strong> are<strong> delayed </strong>because of<strong> fetal haemoglobin.</strong> Here also<strong> no accumulation of glycolytic intermediates.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase deficiency</strong> is a cause of <strong>congenital non-spherocytic hemolytic anemia</strong>, characterized by <strong>elevated levels of certain</strong> <strong>glycolytic intermediates</strong> due to<strong> impaired ATP production</strong> in red blood cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 168, 693-694.</span></span></strong></p>",
      "correct_choice_id": 30729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6122,
      "choices": [
        {
          "id": 24457,
          "text": "<p><span style=\"font-size:12pt;\">Glucokinase</span></p>"
        },
        {
          "id": 24458,
          "text": "<p><span style=\"font-size:12pt;\">Hexokinase</span></p>"
        },
        {
          "id": 24459,
          "text": "<p><span style=\"font-size:12pt;\">PFK</span></p>"
        },
        {
          "id": 24460,
          "text": "<p><span style=\"font-size:12pt;\">Enolase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">During a review of laboratory practices, a medical student is presented with a case study. A 55-year-old woman underwent routine blood work at 8 am in plain Vacutainer, but her blood glucose level was not processed until 11 am, with results reported at noon showing a blood glucose level of 48 mg/dl, despite all other tests being normal. Sample for blood glucose should be taken in Vacutainer containing NaF because it inhibit the following enzyme:</span></p>",
      "unique_key": "Q4552782",
      "question_audio": null,
      "question_video": null,
      "map_id": 29823,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Enolase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In blood samples collected for glucose estimation, it’s crucial to prevent glycolysis (the breakdown of glucose by blood cells), which continues even after blood is drawn. If left unchecked, this can artificially lower blood glucose levels over time, as in the case described where the delay led to a falsely low glucose reading (48 mg/dL).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To prevent this:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Blood for glucose estimation is collected in gray-top Vacutainers containing:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Sodium fluoride (NaF): an inhibitor of glycolysis,</span></li><li><span style=\"font-size:12.0pt;\">Often combined with potassium oxalate (an anticoagulant).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sodium fluoride inhibits the enzyme:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Enolase, which catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate (PEP) in the glycolytic pathway.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Although NaF acts late in glycolysis, it is effective because it eventually halts the entire pathway, preserving glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Glucokinase</strong>:</span><br><span style=\"font-size:12.0pt;\">Enzyme in the liver and pancreas (not in RBCs), catalyzes glucose to glucose-6-phosphate. Not inhibited by NaF.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Hexokinase</strong>:</span><br><span style=\"font-size:12.0pt;\">Catalyzes the first step of glycolysis in most tissues, converting glucose to glucose-6-phosphate. Not the target of NaF.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. PFK (Phosphofructokinase</strong>):</span><br><span style=\"font-size:12.0pt;\">A key rate-limiting enzyme of glycolysis, but again, NaF does not inhibit PFK.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This question highlights the importance of proper pre-analytical handling of blood samples for glucose testing. Blood samples should either be processed immediately or collected in tubes containing glycolysis inhibitors (such as sodium fluoride) to prevent falsely lowered glucose results due to continued cellular metabolism. The case demonstrates how delayed processing can lead to clinically significant errors in laboratory results, potentially misleading diagnosis and treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/e: 111.</span></p>",
      "correct_choice_id": 24460,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6139,
      "choices": [
        {
          "id": 24525,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hexokinase</span></span></span></p>"
        },
        {
          "id": 24526,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucokinase</span></span></span></p>"
        },
        {
          "id": 24527,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphofructokinase&nbsp;&nbsp; </span></span></span></p>"
        },
        {
          "id": 24528,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a research project focusing on glucose metabolism, a group of medical students observe that ATP is produced in the cytosol before the breakdown products of glucose enter the mitochondria. This finding highlights an important step in the glycolytic pathway. Which enzyme involved in glucose metabolism is responsible for this early ATP generation in the cytosol?</span></span></span></p>",
      "unique_key": "Q2446294",
      "question_audio": null,
      "question_video": null,
      "map_id": 29822,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pyruvate kinase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase</strong> <strong>catalyzes</strong> <strong>last </strong>and an<strong> irreversible step of glycolysis</strong> and is a <strong>regulatory enzyme</strong> of glycolysis. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When<strong> energy is in plenty </strong>in the cell, <strong>glycolysis is inhibited. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin</strong> <strong>increases</strong> its<strong> activity </strong>whereas<strong> glucagon inhibits it. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase</strong> is<strong> inactive</strong> in the <strong>phosphorylated state. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic anaemia</strong>, because of <strong>destruction of energy</strong> <strong>depleted RBCs.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture19_T9tgs1j.jpg\" style=\"height:351px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hexokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Catalyzes the <strong>first step</strong> of <strong>glycolysis, phosphorylating glucose to glucose-6-phosphate</strong>, but does<strong> not </strong>directly result in <strong>ATP generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Functions similarly to hexokinase but is<strong> specific to the liver and pancreatic &beta;-cells, </strong>also<strong> not </strong>directly involved in <strong>ATP generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Phosphofructokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A key <strong>regulatory enzyme</strong> in glycolysis that <strong>catalyzes</strong> the conversion of <strong>fructose-6-phosphate to</strong> <strong>fructose-1,6-bisphosphate,</strong> <strong>not </strong>directly involved in<strong> ATP generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase</strong> is involved in the <strong>last step </strong>of the <strong>glycolytic pathway, </strong>where it catalyzes the <strong>conversion of phosphoenolpyruvate</strong> (PEP) <strong>to pyruvate</strong>, generating<strong> ATP </strong>in the process. This <strong>occurs</strong> in the<strong> cytosol</strong> and is <strong>one </strong>of the<strong> steps in glycolysis</strong> that produces<strong> ATP</strong> <strong>before the metabolites</strong> <strong>enter</strong> the<strong> mitochondria </strong>for further <strong>energy</strong> <strong>production</strong> processes like the <strong>citric acid cycle</strong> and <strong>oxidative</strong> <strong>phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 168-172.</span></strong></span></span></p>",
      "correct_choice_id": 24528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}